Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:9:641.
doi: 10.1038/msb.2012.66.

Genome-scale engineering for systems and synthetic biology

Affiliations
Review

Genome-scale engineering for systems and synthetic biology

Kevin M Esvelt et al. Mol Syst Biol. 2013.

Abstract

Genome-modification technologies enable the rational engineering and perturbation of biological systems. Historically, these methods have been limited to gene insertions or mutations at random or at a few pre-defined locations across the genome. The handful of methods capable of targeted gene editing suffered from low efficiencies, significant labor costs, or both. Recent advances have dramatically expanded our ability to engineer cells in a directed and combinatorial manner. Here, we review current technologies and methodologies for genome-scale engineering, discuss the prospects for extending efficient genome modification to new hosts, and explore the implications of continued advances toward the development of flexibly programmable chasses, novel biochemistries, and safer organismal and ecological engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
A historical timeline of selected advances leading to genome-scale engineering.
Figure 2
Figure 2
Foundational genome engineering tools and approaches are needed to extend single site genetic perturbations of a single genome to multiple changes across many genomes.
Figure 3
Figure 3
Mechanisms of various targeted genome-modification tools. Integrases can insert a circular donor construct into a recognition site on the genome. Recombinase-mediated cassette exchange (RMCE) involves the replacement of a target sequence flanked with recognition sites with a donor cassette flanked by compatible sites. Homologous recombination using double-stranded DNA cassettes enables programmable target replacement using RecA or RecET-like machinery, which can be stimulated via site-specific cleavage using zinc-finger, CRISPR, or TAL nucleases. Group II introns and insertional elements can be designed to insert into site-specific genome targets. Oligo-mediated allelic replacement incorporates short oligonucleotides into the lagging strand of replicating DNA, which are then resolved upon subsequent cell divisions to inherit the designed mutation.
Figure 4
Figure 4
Strategies for genome-scale engineering by multiplexed in vivo editing or de novo synthesis. Multiplex genome editing enables construction of new genomes via living intermediates for rapid design and test cycles. De novo genome synthesis can build synthetic designs that are drastically different from natural genomes.
Figure 5
Figure 5
Current approaches to genome-scale engineering for building (editing versus synthesis) and testing (screening versus selection) genomes, when considering number of genetic perturbations against total number of mutants generated.
Figure 6
Figure 6
Toward the construction of a flexibly programmable chassis. Genome minimization reduces biological complexity and redundancy. Whole-genome codon remapping enables orthogonal information encoding and expansion of the genetic code. De novo genome synthesis and reconstitution from natural genomes enables creation of semi-synthetic and chimeric genomes with new and hybrid features. Whole-genome redesign and rewiring of regulatory systems enable new synthetic circuitries that are easier to design and model.

References

    1. Agarwal KL, Yamazaki A, Cashion PJ, Khorana HG (1972) Chemical synthesis of polynucleotides. Angew Chem Int Ed Engl 11: 451–459 - PubMed
    1. Akopian A, He J, Boocock MR, Stark WM (2003) Chimeric recombinases with designed DNA sequence recognition. Proc Natl Acad Sci USA 100: 8688–8691 - PMC - PubMed
    1. Albert H, Dale EC, Lee E, Ow DW (1995) Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J 7: 649–659 - PubMed
    1. Alper H, Miyaoku K, Stephanopoulos G (2005) Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotechnol 23: 612–616 - PubMed
    1. Alper H, Stephanopoulos G (2007) Global transcription machinery engineering: a new approach for improving cellular phenotype. Metab Eng 9: 258–267 - PubMed

Publication types